1 out of 2 analysts covering the stock have rated
Post# of 219
(Total Views: 491)
Posted On: 12/10/2018 5:37:25 PM
1 out of 2 analysts covering the stock have rated it a Buy, while 0 have maintained a Hold recommendation on Synthetic Biologics, Inc. stock. 0 analysts has assigned a Sell rating on the SYN stock. The 12-month mean consensus price target for the company’s shares has been set at $106.50.
$106.50 / that's funny .
$106.50 / that's funny .
(0)
(0)Theriva Biologics, Inc. (TOVX) Stock Research Links
Scroll down for more posts ▼